Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Subependymoma of the septum pellucidum: characterization by PET.

Literature DB >> 9120543

Subependymoma of the septum pellucidum: characterization by PET.

K Mineura¹, H Shioya, M Kowada, T Ogawa, J Hatazawa, K Uemura.

Abstract

We report the evaluation of a subependymoma of the septum pellucidum by positron emission tomography (PET) with analysis of 18F-fluorodeoxyglucose (FDG) kinetics. The tumor showed exceedingly low rates of glucose metabolism (rCMRG1) and kinetic constants (K1, K2, and K3). This hypometabolism indicates low cellular density and slow growth.

Entities: Chemical Disease Gene

Mesh：

Substances：

Year: 1997 PMID： 9120543 DOI： 10.1023/a:1005784020134

Source DB: PubMed Journal: J Neurooncol ISSN： 0167-594X Impact factor: 4.130

18 in total

1. Intracranial ependymoma and subependymoma: MR manifestations.

Authors: G P Spoto; G A Press; J R Hesselink; M Solomon
Journal: AJNR Am J Neuroradiol Date: 1990 Jan-Feb Impact factor: 3.825

2. Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool.

Authors: G Di Chiro
Journal: Invest Radiol Date: 1987-05 Impact factor: 6.016

Review 3. Clinical application of PET for the evaluation of brain tumors.

Authors: R E Coleman; J M Hoffman; M W Hanson; H D Sostman; S C Schold
Journal: J Nucl Med Date: 1991-04 Impact factor: 10.057

Review 4. The applications of PET in clinical oncology.

Authors: L G Strauss; P S Conti
Journal: J Nucl Med Date: 1991-04 Impact factor: 10.057

Review 5. Familial occurrence of subependymoma. Report of two cases.

Authors: T C Ryken; R A Robinson; J C VanGilder
Journal: J Neurosurg Date: 1994-06 Impact factor: 5.115

6. Perfusion and metabolism in predicting the survival of patients with cerebral gliomas.

Authors: K Mineura; T Sasajima; M Kowada; T Ogawa; J Hatazawa; F Shishido; K Uemura
Journal: Cancer Date: 1994-05-01 Impact factor: 6.860

7. Symptomatic subependymoma: a clinicopathological and flow cytometric study.

Authors: D Lombardi; B W Scheithauer; F B Meyer; G S Forbes; E G Shaw; D J Gibney; J A Katzmann
Journal: J Neurosurg Date: 1991-10 Impact factor: 5.115

8. MRI of intracranial subependymomas.

Authors: J E Silverstein; L Lenchik; M G Stanciu; P M Shimkin
Journal: J Comput Assist Tomogr Date: 1995 Mar-Apr Impact factor: 1.826

9. MRI of intracranial subependymoma: report of a case.

Authors: D G Kim; M H Han; S H Lee; J G Chi; K J Cho; J H Kim; K S Choi; D H Han
Journal: Neuroradiology Date: 1993 Impact factor: 2.804

10. Supratentorial ependymomas and subependymomas: CT and MR appearance.

Authors: D M Furie; J M Provenzale
Journal: J Comput Assist Tomogr Date: 1995 Jul-Aug Impact factor: 1.826

3 in total

Review 1. Spinal cord ependymoma: a review of the literature and case series of ten patients.

Authors: Emma Celano; Arsalaan Salehani; James G Malcolm; Erik Reinertsen; Constantinos G Hadjipanayis
Journal: J Neurooncol Date: 2016-05-06 Impact factor: 4.130

2. Clinicopathological study of seven cases of symptomatic supratentorial subependymoma.

Authors: So-Hyang Im; Sun Ha Paek; Yoon-La Choi; Je G Chi; Dong Gyu Kim; Hee-Won Jung; Byung-Kyu Cho
Journal: J Neurooncol Date: 2003-01 Impact factor: 4.130

Review 3. Imaging in neurooncology.

Authors: Andreas H Jacobs; Lutz W Kracht; Axel Gossmann; Maria A Rüger; Anne V Thomas; Alexander Thiel; Karl Herholz
Journal: NeuroRx Date: 2005-04

3 in total